Eckert & Ziegler Strahlen- und Medizintechnik AG

Research Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY) on Bullrun: P/E 30.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker0NZY
• ExchangeLSE
• CountryGermany
• CurrencyEUR
• P/E30.5

Valuation Snapshot

P/E is 30.5.

About Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy;

Frequently asked questions

What is Eckert & Ziegler Strahlen- und Medizintechnik AG's P/E ratio?

Eckert & Ziegler Strahlen- und Medizintechnik AG's price-to-earnings (P/E) ratio is 30.5.

What does Eckert & Ziegler Strahlen- und Medizintechnik AG do?

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125;